HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Douglas H Thamm Selected Research

Aftercare (After-Treatment)

10/2021Canine Non-Angiogenic, Non-Myogenic Splenic Stromal Sarcoma: a Retrospective Clinicopathological Analysis and Investigation of Podoplanin as a Marker of Tumour Histogenesis.
3/2020Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Douglas H Thamm Research Topics

Disease

53Neoplasms (Cancer)
03/2022 - 08/2003
17Lymphoma (Lymphomas)
01/2022 - 03/2002
15Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 01/2003
8Neoplasm Metastasis (Metastasis)
01/2022 - 08/2008
5Hemangiosarcoma (Angiosarcoma)
01/2022 - 08/2006
5Sarcoma (Soft Tissue Sarcoma)
10/2021 - 11/2002
3Breast Neoplasms (Breast Cancer)
01/2022 - 01/2021
3Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2010 - 05/2008
2Leukemia
01/2022 - 01/2014
2Melanoma (Melanoma, Malignant)
01/2022 - 02/2010
2Disease Progression
10/2021 - 01/2007
2Carcinoma (Carcinomatosis)
01/2019 - 09/2003
2Diarrhea
01/2007 - 09/2005
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Glioma (Gliomas)
01/2022
1Bone Neoplasms (Bone Cancer)
12/2021
1Histiocytic Sarcoma
10/2021
1Leiomyosarcoma
10/2021
1Hyperplasia
10/2021
1Liver Neoplasms (Liver Cancer)
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
09/2020
1Circulating Neoplastic Cells
01/2019
1Osteoporosis
12/2018

Drug/Important Bio-Agent (IBA)

17Doxorubicin (Adriamycin)FDA LinkGeneric
10/2021 - 11/2002
10Biological ProductsIBA
01/2022 - 09/2003
8Pharmaceutical PreparationsIBA
01/2022 - 06/2014
7Proteins (Proteins, Gene)FDA Link
10/2021 - 02/2010
6Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 05/2008
6rabacfosadineIBA
01/2022 - 05/2008
5Vincristine (Oncovin)FDA LinkGeneric
03/2021 - 11/2002
5Prednisone (Sone)FDA LinkGeneric
09/2020 - 01/2007
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2022 - 01/2003
4Carboplatin (JM8)FDA LinkGeneric
10/2021 - 07/2004
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2021 - 10/2011
4Messenger RNA (mRNA)IBA
03/2020 - 08/2003
3Auranofin (Ridaura)FDA Link
06/2020 - 01/2018
3Asparaginase (Elspar)FDA Link
03/2020 - 09/2005
3Biomarkers (Surrogate Marker)IBA
01/2019 - 08/2008
3Peptides (Polypeptides)IBA
01/2018 - 09/2014
3NucleotidesIBA
01/2014 - 05/2008
3VaccinesIBA
01/2007 - 11/2002
2toceranib phosphateIBA
03/2022 - 05/2014
2Diphosphonates (Bisphosphonates)IBA
01/2022 - 12/2018
2Lomustine (CCNU)FDA Link
03/2021 - 01/2007
2SurvivinIBA
03/2020 - 01/2012
2GuanineIBA
01/2014 - 05/2009
2ProdrugsIBA
01/2014 - 05/2009
29-((2-phosphonylmethoxy)ethyl)guanineIBA
01/2014 - 05/2009
2Histone Deacetylase InhibitorsIBA
03/2012 - 01/2011
2Valproic Acid (Depakote)FDA LinkGeneric
01/2011 - 10/2010
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2010 - 07/2004
2IGF Type 1 Receptor (IGF 1 Receptor)IBA
02/2010 - 05/2004
1NF-kappa B (NF-kB)IBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Angiotensin Receptor AntagonistsIBA
01/2022
1Drug CombinationsIBA
01/2022
1Losartan (Cozaar)FDA LinkGeneric
01/2022
1GemcitabineFDA Link
12/2021
1Ibandronic Acid (Boniva)FDA Link
12/2021
1Docetaxel (Taxotere)FDA Link
12/2021
1Morphine (MS Contin)FDA LinkGeneric
11/2021
1Histamine (Histamine Dihydrochloride)FDA Link
11/2021
1Indicators and Reagents (Reagents)IBA
10/2021
1RNA (Ribonucleic Acid)IBA
10/2021
1DesminIBA
10/2021
1Scavenger Receptors (Scavenger Receptor)IBA
10/2021
1Eosine Yellowish-(YS) (Eosin)IBA
10/2021
1von Willebrand FactorIBA
10/2021
1AntigensIBA
03/2021
1Bovine Serum AlbuminIBA
01/2021
1SiliconIBA
01/2021
1IonsIBA
01/2021
1Thioredoxin Reductase 2IBA
06/2020
1Antisense OligonucleotidesIBA
03/2020
1locked nucleic acidIBA
03/2020
1EZN 3042IBA
03/2020
1Inhibitor of Apoptosis ProteinsIBA
03/2020
1Ivermectin (Mectizan)FDA Link
08/2019
1Cisplatin (Platino)FDA LinkGeneric
01/2019
1Mitoxantrone (Novantrone)FDA LinkGeneric
01/2019
1Antimicrobial PeptidesIBA
01/2019
1Durapatite (Hydroxylapatite)IBA
12/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2018
1Thioredoxin-Disulfide ReductaseIBA
05/2018
1LigandsIBA
01/2018
1Caspase 3 (Caspase-3)IBA
01/2018

Therapy/Procedure

26Therapeutics
03/2022 - 03/2002
16Drug Therapy (Chemotherapy)
01/2022 - 11/2002
5Surgical Amputation (Amputations)
01/2022 - 03/2010
3Radiotherapy
03/2022 - 01/2016
3CHOP protocol (VDCP protocol)
09/2020 - 09/2005
2Aftercare (After-Treatment)
10/2021 - 03/2020
2Splenectomy
10/2021 - 07/2021
2Immunotherapy
09/2019 - 08/2003
2Combination Drug Therapy (Combination Chemotherapy)
01/2007 - 09/2005
1Time-to-Treatment
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
09/2021
1Precision Medicine
03/2021
1Adjuvant Chemotherapy
01/2019